TGFB3 and exfoliation syndrome: However, the high level of TGF-β3 in patients with XFG suggests that TGF-β3 signaling may be an important therapeutic target for XFG, and we found that the physiological concentration of TGF-β3 can affect the fibrotic reaction in HTM cells and trans-signaling via the ATX–LPA pathway indeed.